Exploring Market Entry Barriers in Brucellosis Vaccine Development The Brucellosis Market is expected to reach USD 0.63 Billion by 2032 at 8.9% CAGR during the forecast period 2023-2032.
Brucellosis, a zoonotic bacterial infection caused by various species of the Brucella genus, remains a significant public health concern globally. This infectious disease primarily affects animals such as cattle, goats, sheep, and pigs, but it can also be transmitted to...